André Volland

4PUBLICATIONS
29CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 04, 2022
SARS-CoV-2 3CLpro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376.

Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi

|Apr 14, 2022
N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitro.

Michaela Lackner, Annika Rössler, André Volland

|Oct 14, 2021
Heparan sulfate proteoglycans serve as alternative receptors for low affinity LCMV variants.

André Volland, Michael Lohmüller, Emmanuel Heilmann

Pageof 1